MindMaze Presents Breakthrough Virtual Reality Technology

CEO to Discuss Pioneering Medical-Grade Virtual Reality Platform

SAN FRANCISCO, May 7, 2014 — (PRNewswire) —

Mindmaze, S.A. has developed the world's leading Virtual Reality (VR) platform, a technology that enables exciting new applications in gaming, brain machine control, and healthcare. The company's medical-grade technology is more powerful and widely applicable than today's consumer-targeted systems. In addition to real-time immersive VR, Mindmaze delivers high-resolution motion capture, gesture recognition, multiple object/user recognition, and augmented reality.

Mindmaze VR technology has been fused with state-of-the-art neuroscience to create the company's first commercialized product -- MindplayTM, a neurorehabilitation product for stroke and brain injury patients. MindplayTM is cost-effective and modular, facilitating care in hospitals, clinics, and even in patients' homes, where the device can be used under the remote care of clinicians. Moreover, the VR technology is fun and engaging, leading to increased time spent in therapy and faster recovery. MindplayTM was validated at Le Centre Hospitalier Universitaire Vaudois (CHUV), one of Europe's preeminent stroke treatment facilities. It will be introduced to UK and German markets in 2014 and the US in 2015.

Designed to adhere to the rigors of medical device regulation, Mindmaze's breakthrough VR boasts robust capabilities not yet seen in consumer-grade VR technologies. For example, Mindmaze has developed a lightweight, wearable Head Mounted Display (HMD) that offers immersive VR, motion capture, gesture recognition, multiple object/user recognition, and augmented reality. Mindmaze uniquely integrates these capabilities with neuroscience-based protocols and on-board neurophysiological measurement systems.

"The combination of neuroscience and VR technology has given us the unique ability to bring a rich VR experience to many applications," said Tej Tadi, PhD, Mindmaze founder and CEO. "Our initial focus on the medical field helped us develop real-time VR with superior object and user recognition. We look forward to bringing these capabilities to gaming and other new markets."

Dr. Tadi will be discussing Mindmaze VR technology as a Speaker at this week's NeuroGaming Conference and Expo, May 7-8 at Metreon, San Francisco.

About Mindmaze, S.A. 

Mindmaze, S.A. was created to commercialize real-time VR technology developed at the Swiss Federal Institute of Technology. The company's first product, MindPlayTM, is a real-time immersive VR system for rehabilitating motor function in stroke patients. MindPlayTM has been released in Switzerland and will be launched in UK and Germany in late 2014. US release is planned for late 2015.

Mr Tej Tadi
MindMaze SA
Chemin de la Dent d’Oche 1A
Ecublens 1024, Switzerland
Email Contact
+41-(0)21-552-0801

http://www.mindmaze.com

Twitter @MindMazeSA

SOURCE Mindmaze, S.A.

Contact:
Mindmaze, S.A.




Review Article Be the first to review this article
Rand3D

SolidCAM: MC SolidCARE Upgrades

Featured Video
Jobs
Senior Mechanical Engineer for Albert Kahn and Associates at Detroit, MI
Structural Engineer for Albert Kahn and Associates at Detroit, MI
ENVIRONMENTAL GRAPHIC DESIGNER for Blitz at San Francisco, CA
Structural Engineer for The Planate Management Group LLC at Perry Point, MD
Upcoming Events
Design for Metal Additive Manufacturing Short Course at Revere Hotel Boston Common 200 Stuart St Boston MA - Nov 27 - 28, 2017
IMTS2018 International Manufacturing Tech Show at McCormick Place Chicago IL - Sep 10 - 15, 2018
Kenesto: 30 day trial
MasterCAM



Internet Business Systems © 2017 Internet Business Systems, Inc.
25 North 14th Steet, Suite 710, San Jose, CA 95112
+1 (408) 882-6554 — Contact Us, or visit our other sites:
AECCafe - Architectural Design and Engineering EDACafe - Electronic Design Automation GISCafe - Geographical Information Services TechJobsCafe - Technical Jobs and Resumes ShareCG - Share Computer Graphic (CG) Animation, 3D Art and 3D Models
  Privacy PolicyAdvertise